J. WARRICK THOMAS, M.D., F.A.C.P.; H. S. VAN ORDSTRAND, M.D.; C. TOMLINSON, M.D.
This study is an evaluation by follow-up examination and questionnaires of sulfonamide therapy and allergy management in the treatment of 75 cases of bronchiectasis. In 13 cases operation was indicated but had been refused or postponed by the patient. The remainder of the cases were considered non-surgical because of minimal or advanced disease, age, general condition, or because benefits from allergy management could be anticipated. The period of observation varied from four months to five years; the majority were observed for two years at least. Consequently, the report is preliminary.
Bronchiectasis was first described by Laennec1 in 1819, but not
THOMAS JW, VAN ORDSTRAND HS, TOMLINSON C. THE TREATMENT OF BRONCHIECTASIS WITH CHEMOTHERAPY AND ALLERGY MANAGEMENT1. Ann Intern Med. ;23:405–413. doi: 10.7326/0003-4819-23-3-405
Download citation file:
Published: Ann Intern Med. 1945;23(3):405-413.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use